mimoleculeindex.com
indexsame ingredientsame route
inspect molecule / dabigatran etexilate

Dabigatran Etexilate

Dabigatran Etexilate Mesylate
  o--o
   \/
   /\
  o--o

Dabigatran Etexilate Mesylate is the active ingredient anchor for this record. Use the ingredient name before comparing brand, country, or pharmacy prices.

active moietyDabigatran Etexilate Mesylate
administration routeOral
price comparison status2 snapshots
safety signal rating46 / 100
Direct Thrombin Inhibitor [EPC]openFDA NDC seedopenFDA NDC75 mg/1
price index

Typical Class Estimates

⚠ Verified price snapshots are queued for this brand/package. Showing typical market estimates based on the drug class: Direct Thrombin Inhibitor [EPC].
$24.50USvsCA$14.20CA

Prices are source-backed snapshots, not medical advice, insurance adjudication, or guaranteed checkout totals.

query trend --id 8703 --12m

Price Trend Index

Deterministic trailing 12-month value delta index for this active ingredient class.

Moderate Growth3M: +1.4%12M: +5.9%
Jul 2025
▂▃▃▅▆▆▇███
Jun 2026
Jan 2026$23.89
Feb 2026$23.89
Mar 2026$24.06
Apr 2026$24.23
May 2026$24.40
Jun 2026$24.40
01 / chemistryXLCare Pharmaceuticals, Inc.

Ingredient Breakdown

active moietyDabigatran Etexilate Mesylate
formulationOral Direct Thrombin Inhibitor [EPC]
mechanism of action

Direct Thrombin Inhibitor [EPC]

available strengths
75 mg/1

label source: registry ↗

02 / ingredientsexcipients

Excipients / Maker Notes

  • Not enriched yet from label source.

Manufacturer Notes

  • This record is normalized from the openFDA NDC seed. Add DailyMed label extraction before treating manufacturer details as complete.
03 / safetyclinical signals

Steps To Take Safely

  1. Confirm ingredient, dose, timing, food instructions, and interaction warnings with a clinician or pharmacist.
  2. Use the same ingredient name when comparing brand, generic, country, and pharmacy options.
  3. Do not split, crush, stop, or substitute extended-release products unless the label or clinician says so.
  4. Watch for severe allergic reactions, bleeding, mood changes, breathing issues, or other label-specific red flags.

Side-Effect Signals

  • label-specific reactions
  • allergic reaction
  • interaction risk
  • dose/formulation confusion
  • urgent symptoms require clinician review
Summary of index signals. Not active medical advice. Consult official labels and clinicians.

$ grep ingredient --same

Same Ingredient Sibling Records

All matches
Dabigatran EtexilateDabigatran EtexilatePradaxaDabigatranDabigatranPradaxaDabigatran EtexilatePradaxa